A detailed history of Aspiriant, LLC transactions in Stryker Corp stock. As of the latest transaction made, Aspiriant, LLC holds 1,196 shares of SYK stock, worth $439,063. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,196
Previous 1,156 3.46%
Holding current value
$439,063
Previous $393,000 9.92%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$315.94 - $371.96 $12,637 - $14,878
40 Added 3.46%
1,196 $432,000
Q2 2024

Jul 15, 2024

SELL
$324.3 - $354.67 $36,970 - $40,432
-114 Reduced 8.98%
1,156 $393,000
Q1 2024

Apr 15, 2024

SELL
$293.94 - $358.71 $5,878 - $7,174
-20 Reduced 1.55%
1,270 $454,000
Q4 2023

Jan 26, 2024

BUY
$253.85 - $299.46 $89,609 - $105,709
353 Added 37.67%
1,290 $386,000
Q3 2023

Oct 17, 2023

BUY
$266.54 - $302.43 $17,058 - $19,355
64 Added 7.33%
937 $256,000
Q4 2022

Jan 23, 2023

BUY
$205.51 - $253.93 $179,410 - $221,680
873 New
873 $0

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $139B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Aspiriant, LLC Portfolio

Follow Aspiriant, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.